278 related articles for article (PubMed ID: 29879072)
1. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
2. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
[TBL] [Abstract][Full Text] [Related]
5. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
6. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
7. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
8. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus Treatment for TAFRO Syndrome.
Shirai T; Ichikawa S; Saegusa J
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791031
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
12. [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
Sumi C; Toki Y; Funayama T; Saito T; Hatayama M; Yamamoto M; Shindo M; Yuzawa S; Tanino M; Okumura T
Rinsho Ketsueki; 2023; 64(4):265-270. PubMed ID: 37121770
[TBL] [Abstract][Full Text] [Related]
13. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
15. TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.
Grange L; Chalayer E; Boutboul D; Paul S; Galicier L; Gramont B; Killian M
Autoimmun Rev; 2022 Aug; 21(8):103137. PubMed ID: 35803499
[TBL] [Abstract][Full Text] [Related]
16. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
19. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
20. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
